Alex Thompson
Stock Analyst at Stifel
(1.85)
# 1,796
Out of 4,412 analysts
28
Total ratings
35%
Success rate
-6.32%
Average return
Main Sectors:
Top Industries:
12 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYRE Spyre Therapeutics | Reiterates: Buy | $36 → $54 | $33.56 | +60.91% | 2 | Mar 26, 2024 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | $44 | $21.50 | +104.65% | 1 | Feb 15, 2024 | |
| VTYX Ventyx Biosciences | Maintains: Hold | $6 → $2 | $3.93 | -49.11% | 5 | Dec 18, 2023 | |
| TVTX Travere Therapeutics | Maintains: Hold | $8 → $10 | $5.26 | +90.11% | 2 | Dec 18, 2023 | |
| MLTX MoonLake Immunotherapeutics | Maintains: Buy | $66 → $69 | $42.49 | +62.39% | 2 | Dec 18, 2023 | |
| ARGX argenx SE | Maintains: Buy | $557 → $560 | $372.80 | +50.21% | 3 | Dec 18, 2023 | |
| ACRS Aclaris Therapeutics | Maintains: Hold | $2 → $1 | $1.20 | -16.67% | 4 | Dec 18, 2023 | |
| MORF Morphic Holding | Maintains: Hold | $61 → $33 | $28.07 | +17.56% | 3 | Sep 25, 2023 | |
| VRDN Viridian Therapeutics | Reiterates: Buy | $40 | $12.88 | +210.56% | 2 | Sep 13, 2023 | |
| RAPT RAPT Therapeutics | Initiates: Buy | $40 | $8.10 | +393.83% | 1 | Aug 9, 2023 | |
| IMVT Immunovant | Maintains: Buy | $28 → $34 | $27.17 | +25.14% | 2 | Jul 18, 2023 | |
| PLRX Pliant Therapeutics | Initiates: Buy | $33 | $11.81 | +179.42% | 1 | Dec 14, 2022 |
Spyre Therapeutics
Mar 26, 2024
Reiterates: Buy
Price Target: $36 → $54
Current: $33.56
Upside: +60.91%
Dianthus Therapeutics
Feb 15, 2024
Initiates: Buy
Price Target: $44
Current: $21.50
Upside: +104.65%
Ventyx Biosciences
Dec 18, 2023
Maintains: Hold
Price Target: $6 → $2
Current: $3.93
Upside: -49.11%
Travere Therapeutics
Dec 18, 2023
Maintains: Hold
Price Target: $8 → $10
Current: $5.26
Upside: +90.11%
MoonLake Immunotherapeutics
Dec 18, 2023
Maintains: Buy
Price Target: $66 → $69
Current: $42.49
Upside: +62.39%
argenx SE
Dec 18, 2023
Maintains: Buy
Price Target: $557 → $560
Current: $372.80
Upside: +50.21%
Aclaris Therapeutics
Dec 18, 2023
Maintains: Hold
Price Target: $2 → $1
Current: $1.20
Upside: -16.67%
Morphic Holding
Sep 25, 2023
Maintains: Hold
Price Target: $61 → $33
Current: $28.07
Upside: +17.56%
Viridian Therapeutics
Sep 13, 2023
Reiterates: Buy
Price Target: $40
Current: $12.88
Upside: +210.56%
RAPT Therapeutics
Aug 9, 2023
Initiates: Buy
Price Target: $40
Current: $8.10
Upside: +393.83%
Immunovant
Jul 18, 2023
Maintains: Buy
Price Target: $28 → $34
Current: $27.17
Upside: +25.14%
Pliant Therapeutics
Dec 14, 2022
Initiates: Buy
Price Target: $33
Current: $11.81
Upside: +179.42%